American Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
American Capital Management's BMY Position: Q1 2017 in Review
American Capital Management sold out of Bristol-Myers Squibb (BMY) in Q1 2017, closing a stake of 7,400 shares — an estimated $432K sold.
American Capital Management first reported a position in BMY in Q4 2015 and held it in 4 quarters. The position peaked at $464K in Q4 2015. 1,597 funds tracked by Wall St. Rank hold BMY as of Q1 2017.
- American Capital Management reported no remaining Bristol-Myers Squibb position as of Q1 2017 after selling out during the quarter.
- American Capital Management sold 7,400 Bristol-Myers Squibb shares in Q1 2017, an estimated $432K.
- American Capital Management first reported a position in Bristol-Myers Squibb in Q4 2015 and held it in 4 quarters.
- American Capital Management's Bristol-Myers Squibb position peaked at $464K in Q4 2015.
- 1,597 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2017.
Based on American Capital Management's 13F filing for Q1 2017, filed 24 Apr 2017.